Showing results (221-230 of 232) with videos related to
Sort By:
Pageof 24
American Journal of Hematology|February 20, 2020
A multicenter retrospective study of 223 patients with t(14;16) in multiple myelomaSarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo, et al.Leukemia & Lymphoma|January 12, 2019
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE studyDaniele Campa, Alessandro Martino, Angelica Macauda, et al.Blood Cancer Journal|April 15, 2021
Genetically determined telomere length and multiple myeloma risk and outcomeMatteo Giaccherini, Angelica Macauda, Enrico Orciuolo, et al.American Journal of Hematology|March 10, 2016
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practiceArtur Jurczyszyn, Norbert Grzasko, Alessandro Gozzetti, et al.International Journal of Cancer|November 5, 2020
Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survivalOmbretta Melaiu, Angelica Macauda, Juan Sainz, et al.International Journal of Cancer|October 9, 2016
Identification of miRSNPs associated with the risk of multiple myelomaAngelica Macauda, Diego Calvetti, Giuseppe Maccari, et al.International Journal of Cancer|March 6, 2021
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patientsAngelica Macauda, Chiara Piredda, Alyssa I Clay-Gilmour, et al.Lancet (London, England)|November 15, 2020
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trialSebastian Grosicki, Maryana Simonova, Ivan Spicka, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, et al.International Journal of Cancer|September 9, 2022
A pleiotropic variant in DNAJB4 is associated with multiple myeloma riskMarco Dicanio, Matteo Giaccherini, Alyssa Clay-Gilmour, et al.Pageof 24